We recently shared a list of 10 Best Short Squeeze Stocks To Buy According to Analysts. In this article, we will see how ...

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE) are dirt cheap now, and why buying these value stocks could be a brilliant ...

The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and ...

Sequoia Financial Advisors LLC grew its stake in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 34.5% in the fourth ...

Altimmune (NASDAQ:ALT – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research ...

Bullish option flow detected in Altimmune (ALT) with 8,561 calls trading, 3x expected, and implied vol increasing almost 4 points to 114.21%.

Shares of Altimmune Inc. are down more than 23% this year, but that has not deterred retail investors from losing hope in the ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies, has been garnering significant attention from analysts ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies, has been garnering significant attention from analysts and ...